Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Biophage appoints new board members

This article was originally published in Scrip

Executive Summary

Biophage Pharma (Canada) has appointed Mr Luc Dubois and Mr Jocelyn Pelchat to its board of directors. Mr Dubois is currently president of the board of Validapro Biosciences, and a biologist expert in the pharmaceutical and biotechnology fields, working on areas from process development to commercial product manufacturing. Dr Pelchat is vice-president of Pharma Concept, and has served in a number of executive, business development and management positions, with companies including Axcan Pharma, Sanofi-Aventis and Novartis.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts